| Product Code: ETC6532479 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 Brunei Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as arthritis and musculoskeletal disorders in Brunei |
4.2.2 Growing geriatric population requiring long-term pain management |
4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) for pain relief |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new NSAID products in Brunei |
4.3.2 Potential side effects associated with long-term use of NSAIDs leading to safety concerns |
5 Brunei Non-steroidal Anti-inflammatory Drugs Market Trends |
6 Brunei Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 Brunei Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.1.4 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.1.5 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.2 Brunei Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F |
6.2.4 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F |
6.2.5 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Brunei Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Brunei Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 Brunei Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 Brunei Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Average prescription renewal rate for NSAIDs in Brunei |
8.2 Number of healthcare providers offering NSAIDs as a primary pain management option |
8.3 Patient adherence rate to NSAID treatment plans |
9 Brunei Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 Brunei Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Brunei Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 Brunei Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024 |
10.2 Brunei Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here